Medical Microbiology articles for China

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 194

Article ‘Count’ for Medical Microbiology.

Journal Count Share
9 8.12
Photoactivated Digital Recombinase Polymerase Amplification/CRISPR-Cas12a Assay for Point-of-Care of BK Polyomavirus Quantification 1.00
Living Cell-Metal Cyborg Microalgae for Treating MRSA Infection 1.00
An Inorganic Stimulator of Interferon Genes Sensitizer for the Metalloimmunotherapy of Intracellular Bacterial Infections 1.00
Engineering Smart Bimetallic Ionic-Site MOF Nanozyme Nanocomposites for Microenvironment-Responsive Dynamic Therapy of Periapical Periodontitis 1.00
Dual-Functional Magnesium-Doped Zeolitic Imidazolate Framework-8 Nanoparticles for Rice Blast Control and Restoration of Magnesium-Deficient Photosynthesis 0.95
Selenium-Containing Nanoscale Hydrogen-Bonded Organic Framework Nanozymes for Multienzyme Cascade Antioxidant-Targeted Therapy of Cerebral Ischemia–Reperfusion Injury 1.00
Enhanced Antibacterial Efficacy of Copper Single-Atom Catalysts on a Two-Dimensional Boron Nitride Platform 0.83
A Dual-Functional Prodrug for Imaging and Eradication of Drug-Resistant Gram-Negative Bacteria 0.33
Nanoflower-Mediated Gallium-Protoporphyrin IX Complex for Intracellular Antibacterial and Immunomodulatory Effects in Macrophage-Targeted Therapy 1.00
4 3.40
Hydrophilic Cationic Surface Modification Confers Simultaneous Antibacterial and Antithrombotic Properties to Blood-Contacting Devices 1.00
Tuning energy transport in helical protein nanotubes through side-chain modifications 0.40
Dextran guanidinylated carbon dots with antibacterial and immunomodulatory activities as eye drops for the topical treatment of MRSA-induced infectious keratitis 1.00
Magnetothermal and ultrasound-activated nanoplatform for the inhalable therapy of bacterial lung infections 1.00
8 7.17
Elesclomol-Loaded Cuprous Oxide Nanozymes with Dual-Enzyme Activities for Implant-Related Infection Therapy by Enhancing Bacterial Cuproptosis-Like Death 1.00
Programmable DNA-Peptide Hybrid Nanostructures for Potent Neutralization of Multiple Influenza a Virus Subtypes 0.17
A Self‐Assembled RSV‐DS2 Based Nanovaccine Elicits a Strong Immune Response Against Respiratory Syncytial Virus Infection 1.00
NIR Light-Controlled Cascade Regulation of Mixed-Valence Copper (I)/(II) Nanozyme (Cu2−xSe) Spray for Infectious Wound Healing 1.00
Copper-Doped Prussian Blue Nanozymes: Targeted Starvation Therapy Against Gram-Positive Bacteria via the ABC Transporter Inhibition 1.00
Bismuth Sulfide Microneedle Patch for MRSA Biofilm Removal via Oxidative Stress Amplification 1.00
Electron Compensation-Mediated Suppression of Silver Ion Release and Enhanced Electrodynamic Therapy for Efficient Eradication of Bacterial Infections 1.00
A Self-Oxidizing o-Dihydroxybenzene-Based Covalent Organic Framework Hydrogel with Broad-Spectrum Antibacterial Properties for Promoting Diabetic Wound Healing 1.00
4 3.75
Biodegradable Nanospray for Sunlight-Activated Photodynamic Antibacterial Therapy and Wound Healing 0.75
Solution‐Processed Flexible Glass‐Like Antibacterial Nanocomposite Coatings 1.00
Precise Strain Tuning of PtPdRhNi Nanozyme Boosts Multi‐Pathogen and Multi‐Model Antibacterial Therapy 1.00
Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus 1.00
1 1.00
Enhancement of TNFα-mediated hepatic apoptosis and liver injury by Hepatitis B virus surface antigen 1.00
1 1.00
Global, Regional, and National Burden of Pulmonary Fungal Infections 1990–2021 1.00
5 5.00
Recombinant Phage Tail Fiber Protein Gp47 Enables Broad-Spectrum Fluorescent Detection of Pseudomonas aeruginosa Strains 1.00
Preparation, Characterization, and Binding Mechanism of Nanobodies Targeting Multiple Serotypes of Salmonella 1.00
Galactose Unit-Based Liposomal Nanoprobes for Pseudomonas aeruginosa Targeting Imaging and In Situ Antibacterial Therapy 1.00
Precise Detection of Carbapenem-Resistant and Hypervirulent iKlebsiella pneumoniae/i Using MOF-Derived Bimetallic Nanocube Hybrid Nanosheet 1.00
Peptide Molecular Siege Machine: Breaking through Mycobacterium tuberculosis’s Cellular Defenses for Precise Detection and Monitoring 1.00
1 1.00
Deep Learning-Enhanced DNAzyme-Driven Rolling-Circle Amplification Encoding for Multibacterial Detection 1.00
6 3.88
Differential inhibition of Morbillivirus and Henipavirus polymerases by ERDRP-0519 and structure-guided inhibitor optimization 0.90
Molecular characterization of Ebola virus glycoprotein V75A substitution in the 2018–2020 epidemic 1.00
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation 0.27
Structurally conserved human anti-A35 antibodies protect mice and macaques from mpox virus infection 1.00
Extensive cross-species transmission of pathogens and antibiotic resistance genes in mammals neglected by public health surveillance 0.66
The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2 0.05
2 1.92
A conserved adaptor orchestrates co-secretion of synergistic type VI effectors in gut Bacteroidota 0.92
A Vibrio-specific T6SS effector reshapes microbial competition by disrupting Vibrio bioenergetics 1.00
2 2.00
Coordination-driven supramolecular metalla-cycles/cages for next-generation antibacterial therapy 1.00
SsrA-based design of BacPROTACs for β-lactamase degradation in Gram-negative bacteria 1.00
1 1.00
Pulmonary toxicity and antibiotic resistance risks induced by environmental MRSA exposure in mice 1.00
1 1.00
Context-informed tracing of blaNDM-1 and chromosomal blaOXA-48 in Shewanella xiamenensis: defining the clinical node within the wastewater-patient continuum 1.00
2 1.80
Integrative Phenotypic and Genotypic Surveillance and Risk Assessment of Foodborne Antimicrobial Resistance in Meat–Environment Continuum 0.80
Exposure to Environmentally Relevant Concentrations of Antibiotics Increases N2O Emissions and Delays Nitrate Removal: New Insights into Bacteriostatic Antibiotics at the Cellular Level 1.00
1 0.96
Vonoprazan–tetracycline dual regimen as rescue therapy for Helicobacter pylori infection: randomized controlled trial 0.96
1 1.00
Long-read sequencing reveals HBV integration patterns and oncogenic impact on early-onset hepatocellular carcinoma 1.00
10 6.55
Nucleotide analogue bemnifosbuvir inhibits hepatitis E virus replication in preclinical models 0.24
Twenty-four-week anti-PD-1 antibody regimen promoted HBsAg reduction and concurrently enhanced HBV-specific T cell responses in patients with chronic hepatitis B 1.00
Engineered virus-hunter vaccine overcomes HBV immune tolerance 1.00
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER) 0.21
EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infection 1.00
iPSC-induced multilineage liver organoids, small intestinal organoids and brain organoids sustain pangenotype hepatitis E virus propagation 1.00
Large-scale profile study on hepatitis B surface antigen levels in chronic hepatitis B: implications for drug development targeting functional cure 1.00
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions 0.03
Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-α 1.00
Differential HCC risk among HBV indeterminate types at baseline and by phase transition 0.08
1 1.00
Host-viral interaction of HBV infection revealed by single-cell transcriptome jointly profiling the viral replication state. 1.00
3 1.76
Pharmacological targeting of the mycothiol cysteine ligase MshC in Mycobacterium abscessus 0.13
A Pseudomonas aeruginosa endolytic muramidase targets cell-wall peptidoglycan in bacterial competition 0.64
Modeling Mycobacterium tuberculosis Pathogenesis in Lung Epithelial Organoids Reveals Strain-Specific Host Responses and Intercellular Crosstalk 1.00
1 1.00
Targeting the host factor HGS-viral membrane protein interaction in coronavirus infection 1.00
6 4.53
A genome-wide siRNA screen identifies previously unknown proviral and antiviral host factors in HBV infection 0.50
HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responses 1.00
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells 0.03
Enhanced surveillance, subtyping, and host adaptation analysis reveal genotype-wide zoonotic potential of rat hepatitis E virus 1.00
Antibodies elicited by hepatitis E vaccination in humans confer cross-genus protection against rat hepatitis E virus 1.00
Attenuation of the second peak of bimodal recurrence of HBV-related HCC after curative treatment in the antiviral era 1.00
7 6.00
Severe Lower Respiratory Tract Infection in Patients With Human Bocavirus Monoinfection in Southeast China 0.93
Decoding Hypervirulence in Carbapenem-Resistant Klebsiella pneumoniae: Genomic and Phenotypic Profiling Reveals Capsular Polysaccharide as a Key Driver of Pathogenicity 1.00
Comparative Analysis of High-Dose Dual Therapies in First-Line Helicobacter pylori Eradication: An Inverse Probability of Treatment-Weighted Multicenter Study 1.00
<atl>iBartonella henselae/i Subverts Host Cell Apoptosis by Linking Intracellular NOD2 Sensing to an AREG/EGFR Autocrine Survival Loop</atl> 1.00
Phospholipid transporter MlaFEDCB regulates iKlebsiella pneumoniae/i virulence by modulating fimbriae synthesis and stress-adaptive growth 1.00
Prognostic Divergence in Human Immunodeficiency Virus/Hepatitis B Virus Versus Hepatitis B Virus–Associated Hepatocellular Carcinoma After Resection: Intrahepatic Pre-S Deletions Mutants and T-Cell Depletion Under Viral Suppression 1.00
Functional Genomics of Antibiotic Susceptibility in iEnterococcus faecalis/i From Infective Endocarditis 0.06
1 1.00
Inhibitor-Dependent Tolerance of New Delhi Metallo-β-Lactamase Driven by Single Mutation-Induced Conformational Changes 1.00
2 0.97
CuInP2S6 Captures Virus for Viral Inhibition and Vaccine Adjuvanticity 0.82
Silver-Loaded Titania-Based Metal–Organic Frameworks as a Platform for Silver Ion Release for Antibacterial Applications 0.14
3 1.78
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk 0.84
SuFEx-based antitubercular compound irreversibly inhibits Pks13 0.04
R9AP is a common receptor for EBV infection in epithelial cells and B cells 0.89
73 62.56
Ultrastructural and atomic characterization of biofilm-associated extracellular filaments in Shewanella oneidensis MR-1 1.00
Nasopharyngeal carcinoma screening using Epstein–Barr virus Cp methylation triage in two population-based screening cohorts 0.86
Spatial transcriptomic atlas of murine neurotoxocariasis reveals region-specific host responses and dysfunction in the brain 0.85
Next-generation inhibitors of SARS-CoV-2 M overcome the deficiencies of Paxlovid 1.00
Targeting phenol-soluble modulin α3-driven M1 macrophage polarization and necroptosis mitigates MRSA infection in mice 1.00
High-risk EBV promotes immune evasion in nasopharyngeal carcinoma by upregulating HLA-DP via the encoded BALF2-HR variant 0.98
Copper single-atom nanozyme with intelligent capture and photo-enhanced activity for controlling plant bacterial diseases 1.00
A mouse-adapted Yezo virus model for antiviral testing in immunocompetent mice 1.00
A highly potent nanobody-based bispecific therapeutic provides broad-spectrum protection against ebolavirus 1.00
The conserved human astrovirus-receptor interface reveals a targetable vulnerability for antiviral development 1.00
Distinct genomic trajectory among invasive Salmonella Typhimurium ST313 infections 1.00
Inhibiting Mrt4-rRNA interaction with fumaramidmycin-based derivatives as an antifungal strategy 0.94
Effector conformational plasticity enables lineage-specific secretion via Hcp heterohexamers in gut symbionts 1.00
The crucial but insufficient role of E2s domain’s residues 490 and 492 in determining the host tropism of hepatitis E virus 1.00
YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in mice 1.00
Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants 0.92
Dual-functional quorum sensing signal synthases DspII and DspI coordinate virulence switch in Pseudomonas aeruginosa 1.00
Sero-genomic evidence for occult mpox exposure in healthy Nigerian adults 0.01
Tissue-specific and sex-biased glycoproteomic landscape of 1.00
Efficacy of two rounds of albendazole treatment on soil-transmitted helminths in schoolchildren, Yunnan Province, China 0.24
Retrospective cohort study of hepatitis B immunization strategy effects in Beijing across 30 years 1.00
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study 0.82
Intervention timing and disease stage shape tecovirimat and cidofovir efficacy in male SCID mice 1.00
Molecular mechanisms of receptor recognition and antibody neutralization of coxsackievirus A6 1.00
Long-term protection from naturally acquired immunity against hepatitis E virus reinfection 1.00
Small molecule inhibitor targets OmpV to treat pandemic Vibrio cholerae infection 1.00
Increased risk of antimicrobial resistance in patients with cirrhosis and hepatic encephalopathy using rifaximin 0.14
A Pseudomonas aeruginosa quorum-sensing inducer controls lung permeability in establishing chronic infection via EGFR 1.00
Structural insights into VLDLR recognition by western equine encephalitis virus 1.00
Immune profiling of mpox survivors reveals divergent durability of antibody and T cell responses 1.00
Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolution 0.90
Coronaviral nsp6 hijacks ERAD machinery to facilitate lipolysis and supply membrane components for DMV growth 1.00
UHRF1 restricts HCoV-229E infection through epigenetic silencing of the viral receptor APN 1.00
Prognostic value of an abnormal chest X-ray result in predicting the development of tuberculosis 0.87
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study 0.89
Neutralizing antibodies against Chikungunya virus and structural elucidation of their mechanism of action 1.00
Structural insights into the secretin complex of a type IVb pilus system 1.00
Extracellular vesicles derived EBV tegument protein BRRF2 suppresses cGAS phase separation to promote anti-viral innate immune evasion 1.00
Node role of wild boars in virus circulation among wildlife and domestic animals 1.00
Epigenetically conferred ring-stage survival in against artemisinin treatment 0.72
Coordinated regulation of pH alkalinization by two transcription factors promotes fungal commensalism and pathogenicity 1.00
Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment 1.00
The pathogenicity and multi-organ proteomic profiles of Mpox virus infection in SIVmac239-infected rhesus macaques 1.00
A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection 1.00
Ecological connectivity of genomic markers of antimicrobial resistance in Escherichia coli in Hong Kong 0.77
RIPK1 kinase drove brain microvascular endothelial cells death and blood-brain barrier disruption in neonatal meningitis 1.00
The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trial 1.00
Tiantan vaccinia virus-based vaccine with promising safety provides sustained protection against mpox in non-human primates 1.00
Virus-human chromatin interactions reorganise 3D genome and hijack KDM5B for promoting metastasis in nasopharyngeal carcinoma 0.96
2-oxoglutarate:acceptor oxidoreductase-catalyzed redox cycling effectively targets coccoid forms of Helicobacter pylori 1.00
SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study 0.89
Biomarkers of pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis through single-cell transcriptomics 0.95
Diversity and transmission and zoonotic potential of microbes in true insectivores 0.91
The crystal structure of coronavirus RBD-TMPRSS2 complex provides basis for the discovery of therapeutic antibodies 1.00
An orally available M/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo 1.00
Host protein ARF1 is a proviral factor for SARS-CoV-2 and a candidate broad-spectrum therapeutic target 1.00
Structural basis for engagement of Western Equine Encephalitis Virus with the PCDH10 receptor 1.00
Vesicle-associated membrane protein 5 is an intrinsic defense factor for embryonic stem cells against coronaviruses 1.00
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants 0.13
Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China 0.94
CRISPRi screen identifies FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa 0.75
Colistin enhances caspofungin antifungal efficacy against by modulating calcium homeostasis and stress responses 0.11
Tracking international and regional dissemination of the KPC/NDM co-producing 1.00
Lactate promotes invasive liver abscess syndrome by increasing capsular polysaccharide biosynthesis via the PTS-CRP axis 1.00
Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens 0.06
Structure and assembly of the MmpL5/MmpS5 efflux transporter from Mycobacterium tuberculosis 0.65
Characteristics of the first confirmed case of human infection with mpox virus clade Ib in China 1.00
Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris 1.00
Hepatitis B virus surface antigen drives T cell immunity through non-canonical antigen presentation in mice 1.00
A global atlas and drivers of antimicrobial resistance in Salmonella during 1900-2023 1.00
Macrophage-augmented intestinal organoids model virus-host interactions in enteric viral diseases and facilitate therapeutic development 0.20
Leishmania sand fly-transmission is disrupted by Delftia tsuruhatensis TC1 bacteria 0.06
Saddle curvature association of nsP1 facilitates the replication complex assembly of Chikungunya virus in cells 0.04
2 1.06
Evaluation of antimicrobial resistance governance across 193 countries to inform the 2026 Global Action Plan update 0.67
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial 0.39
1 0.58
Livestock antimicrobial use embodied in global supply chains 0.58
2 1.07
A bacterial ecocline in Klebsiella pneumoniae may explain its backboned phylogeny 1.00
Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection. 0.07
1 0.92
Genomic profiling and experimental validation of type VI secretion system-associated proteins in Klebsiella. 0.92
17 12.60
The low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virus 0.08
The SMARCA4–TMEM47 axis plays an essential role in chikungunya virus RNA replication 1.00
EIF4H and YBX1 are essential host factors for hepatitis E virus replication and pathogenesis 0.69
Cryo-EM structure of locked spike glycoprotein from bat SARS-like coronavirus WIV1, molecular dynamics and biophysics across host range 0.50
Decoding antibody response to MERS-CoV in wild dromedary camels 0.70
Structural basis of mpox virus A30/H2 subcomplex formation 1.00
SARS-CoV-2 S assembly into virions facilitated by host ERM proteins 1.00
SARS-CoV-2 peptide fragments selectively dysregulate specific immune cell populations via Gaussian curvature targeting 0.24
Glycosylation of GETV E2 promotes pathogenesis in animal models 1.00
Origin and adaptive evolutionary trajectory of the 3′ UTR–derived sRNA UhpU in Enterobacteriaceae 1.00
The prion-like characteristic of ORF3 contributes to virion release and pathogenesis of hepatitis E virus 0.94
Flagellar location determines the stability of bacterial surface entrapment 1.00
A nonenzymatic effector disrupts Bacteroides cell wall homeostasis via OmpA targeting to mediate interbacterial competition 0.93
Fatty acid 2-hydroxylase facilitates rotavirus uncoating and endosomal escape 0.21
Tat-dependent bundling pilus of a halophilic archaeon assembles by a strand donation mechanism and facilitates biofilm formation 0.38
A granulin-positive macrophage subtype in mycobacterial granulomas alleviates tissue damage by limiting excessive inflammation 0.95
Host complement C3 promotes malaria transmission by killing symbiotic bacteria in the mosquito midgut 1.00
5 3.67
RTX-family toxin EhxA drives morphological remodeling and thrombogenesis in RBCs during enterohemorrhagic Escherichia coli infection 0.17
Chemically tailored anionic antibiotic adjuvants targeting divalent cations to overcome carbapenem resistance in gram-negative bacteria 1.00
Structures and receptor binding activities of merbecovirus spike proteins reveal key signatures for human DPP4 adaptation 1.00
Development of enhanced HIV-1 non-nucleoside reverse transcriptase inhibitors with improved resistance and pharmacokinetic profiles 0.50
Astrocytes-derived LCN2 triggers EV-A71–induced muscle soreness via accumulating lactate 1.00
3 2.16
Antibody cocktails based on the occupationally acquired immunity of pediatricians neutralize and confer protection against RSV and hMPV 1.00
An antibody cocktail targeting conserved, nonoverlapping epitopes prevents viral escape and confers protection against RSV in vivo 1.00
Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions 0.16
1 0.02
Drug treatments for mild or moderate covid-19: systematic review and network meta-analysis 0.02
1 0.60
Regional and type-specific variations in the global seasonality of human parainfluenza viruses and the influence of climatic factors: a systematic review and meta-analysis 0.60
1 0.04
Clesrovimab for Prevention of RSV Disease in Healthy Infants 0.04
2 1.42
Sec62 restricts ER-replicating positive-strand RNA virus infections via UPR-dependent ER-phagy 0.92
The phase-separating iMagnaporthe oryzae/i MoSpa2 complex organizes actin nucleation centers for plant infection 0.50
1 1.00
Enhanced diagnosis of tuberculous pleurisy using a multiplex droplet digital PCR assay targeting circulating mycobacterial DNA 1.00
1 1.00
UV-Induced VBNC state formation and resuscitation in E. coli: ATP-based metabolic activation and biofilm-mediated recovery 1.00

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.